Jiajun Du
Impact in
- Oncology top 5%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Health Informatics top 5%
Papers in
-
- Lung Cancer Diagnosis and Treatment 16
- Lung Cancer Treatments and Mutations 16
- Ferroptosis and cancer prognosis 7
- Oncology 26
- Inflammatory Biomarkers in Disease Prognosis 10
- Cancer Immunotherapy and Biomarkers 8
- Lung Cancer Research Studies 5
- Co-authors
- Hongchang Shen (26 shared papers)Guanghui Wang (10 shared papers)Qi Liu (7 shared papers)Hongtao Lu (4 shared papers)Pingping Hu (4 shared papers)Frede Donskov (1 shared paper)Zhaofei Pang (14 shared papers)Yang Ni (6 shared papers)
- Journals
- PLoS ONE (6 papers)Medicine (5 papers)Future Oncology (5 papers)Journal of Cancer (3 papers)Medical Oncology (3 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Jiajun Du
93 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 132
- Oncology 771
- Health Informatics 29
- Cancer Research 221
- Immunology 273
- Pulmonary and Respiratory Medicine 367
Countries citing papers authored by Jiajun Du
This map shows the geographic impact of Jiajun Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiajun Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiajun Du more than expected).
Fields of papers citing papers by Jiajun Du
This network shows the impact of papers produced by Jiajun Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiajun Du. The network helps show where Jiajun Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiajun Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 273 | |
| 2 | 2019 | 199 | |
| 3 | 2014 | 132 | |
| 4 | 2019 | 99 | |
| 5 | 2013 | 81 | |
| 6 | 2016 | 71 | |
| 7 | 2019 | 63 | |
| 8 | 2022 | 49 | |
| 9 | Tumor-stroma ratio is an independent predictor for survival in NSCLC. | 2015 | 48 |
| 10 | 2012 | 45 | |
| 11 | 2015 | 44 | |
| 12 | 2008 | 40 | |
| 13 | 2015 | 40 | |
| 14 | 2013 | 40 | |
| 15 | 2014 | 38 | |
| 16 | 2016 | 33 | |
| 17 | 2014 | 33 | |
| 18 | 2015 | 31 | |
| 19 | 2014 | 30 | |
| 20 | 2019 | 30 |
About Jiajun Du
Jiajun Du is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 96 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (16 papers), Lung Cancer Treatments and Mutations (16 papers), Inflammatory Biomarkers in Disease Prognosis (10 papers), Cancer Immunotherapy and Biomarkers (8 papers), Ferroptosis and cancer prognosis (7 papers), Esophageal Cancer Research and Treatment (7 papers), RNA modifications and cancer (6 papers) and Lung Cancer Research Studies (5 papers). The work is most often cited by research in Oncology (771 citations), Health Informatics (29 citations), Cancer Research (221 citations), Immunology (273 citations) and Pulmonary and Respiratory Medicine (367 citations). Jiajun Du has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Hongchang Shen, Guanghui Wang, Qi Liu, Hongtao Lu, Pingping Hu, Frede Donskov, Zhaofei Pang, Yang Ni, Pingping Hu and Qi Liu. Their work appears in journals such as PLoS ONE, Medicine, Future Oncology, Journal of Cancer and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.